Brief: Wpd And Cns Pharmaceuticals Announce Positive Opinion Of Polish Central Ethics Committee For Wpd-201 Study And Central Irb Study Level Approval For Cns-201 Study
18/02/2021 14:32
Feb 18 (Reuters) - CNS Pharmaceuticals Inc CNSP.O :
* WPD AND CNS PHARMACEUTICALS ANNOUNCE POSITIVE OPINION OF
POLISH
CENTRAL ETHICS COMMITTEE FOR WPD-201 STUDY AND CENTRAL IRB STUDY
LEVEL APPROVAL FOR CNS-201 STUDY
Source text for Eikon: ID:nPn5Mqmm1a
Further company coverage: CNSP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WPD Pharmaceuticals
See all newsBrief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
Brief: WPD Pharmaceuticals Signs Annex To License Agreement With Wake Forest University Health Sciences
Brief: WPD Pharmaceuticals Announces Proposed Restructuring Of Polish Subsidiary
Brief: WPD Pharmaceuticals Enters Into Amended And Restated Sublicense Agreement With Moleculin Biotech